This randomized control trial (RCT) aims to test the effect of a 12 weeks tailored behavioral intervention on stroke survivors living in the community and compare the results to a control group of stroke survivors participating in standard care. The intervention's purpose is to lower the time spend with sedentary behavior and raise the level of physical activity in stroke survivors throughout their everyday life. The intervention contains two motivational interviews with a focus on goal setting, action planning, motivation, fatigue management, and general information on life after stroke. The primary outcome for behavior change is objectively measured physical activity using an activity tracker (ActivPal4 Micro) and secondary glycohemoglobin and changes in quality of life.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
100
Behavior change intervention focuses on implementing more movement into everyday life using action planning, goal setting, and fatigue management.
Zealand University hospital
Roskilde, Denmark
RECRUITINGSedentary time
Time participants spend with sedentary behavior compared between the intervention and control group
Time frame: 12 weeks follow-up
Physical activity scale (PAS2)
Subjective physical activity
Time frame: Baseline,12 and 26 weeks follow-up
The Stroke Specific Quality of Life Scale (SS-QOL)
Quality of life
Time frame: Baseline,12 and 26 weeks follow-up
The General Self-efficacy Scale (GSES)
self-efficacy
Time frame: Baseline,12 and 26 weeks follow-up
The Multi-dimensional Fatigue Inventory (MFI-20) questionnaire
Fatigue
Time frame: Baseline,12 and 26 weeks follow-up
Patient health questionnaire (PHQ-9)
Depression symptoms
Time frame: Baseline,12 and 26 weeks follow-up
The Fugl Meyer Assessment (FMA)
The function of upper and lower extremity
Time frame: Baseline,12 and 26 weeks follow-up
Timed Up & Go (TUG) test
Mobility
Time frame: Baseline,12 and 26 weeks follow-up
Montreal Cognitive Assessment (MoCA)
cognitive assessment
Time frame: Baseline
Glycated hemoglobin (HbA1c)
Glycated hemoglobin (HbA1c)
Time frame: Baseline,6,12 and 26 weeks follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.